Advertisement

Topics

Latest Bioinformatics NewsRSS

05:11 EST 21st February 2017 | BioPortfolio

GB HealthWatch Launches GBinsight Genetic Testing and Analysis to Dissect the Genetic Basis of Type 2 Diabetes, Heart Disease and Obesity

GBinsight is a comprehensive and targeted next-generation DNA sequencing (NGS) assay designed to analyze the genetic architecture of complex diseases. Combined with a novel state-of-the-art bioinformatics analysis algorithm, GBinsight genetic testing and analysis promises to help scientists and clinicians gain genetic insights of common metabolic diseases and facilitate research on personalized pr...

Intellia Therapeutics Inc NTLA Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryIntellia Therapeutics Inc Intellia Therapeutics is a genome editing company that develops curative therapeutics utilizing CRISPR/Cas9, a biological tool. The company develops in vivo programs focused on liver diseases including transthyretin amyloidosis, alpha1 antitrypsin deficiency, hepatitis b virus and inborn errors of metabolism; and ex vivo programs focused on chimeric antigen recepto...

Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma

New format directly addresses DNA extraction, one of the key sources of variability in cfDNA assays Reference standard provides control throughout entire molecular assay workflow Cambridge, UK, 20 February 2017: Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies including molecular reference standards, toda...

Surgical Notes to Attend Ambulatory Surgery Center Conferences & Tradeshows in 2017

DALLAS, Feb. 20, 2017 /PRNewswire/ -- Surgical Notes, a nationwide provider of revenue cycle services and solutions for the ambulatory surgery center (ASC) and surgical hospital markets, will be exhibiting at a number of ASC conferences and tradeshows this year. Attendees of these meetings are encouraged to visit Surgical Notes' exhibit booth to learn about the company's scalable ASC rev...

ZirMed Expands Innovative Charge Integrity Solution to Improve Health System Reimbursement

ORLANDO, Fla., Feb. 20, 2017 /PRNewswire/ -- HIMSS CONFERENCE – BOOTH 4871 – ZirMed Inc., a recognized leader in cloud-based revenue cycle software and predictive analytics, today announced an expansion of its proven Charge Integrity solution, which more than 500 hospitals rely on each day. Health systems will now be able to further integrate professional charges to uncover coding and cha...

Survey: Over 80 Percent of New CRISPR Users are Conducting Gene Editing for the First Time

REDWOOD CITY, CA -- (Marketwired) -- 02/20/17 -- Synthego, a leading provider of genome engineering solutions, today announces the results of its 2017 Future of CRISPR Research, a survey of scientists and researchers about CRISPR trends and experimentation. The survey revealed that 87 percent of new CRISPR users are also new to gene editing -- showing the tremendous interest and effect of CRISPR'...

Synthego Release: Survey: Over 80 Percent Of New CRISPR Users Are Conducting Gene Editing For The First Time

  Life Sciences Jobs   ...

3billion Starts Beta Service for Comprehensive Rare Disease Screening

Seoul, Korea, South, February 18, 2017 --(PR.com)-- 3billion is starting its close beta rare disease screening service with 100 pre-selected patients. Using whole exome and genome analysis, 3billion screens for over 4,000 rare diseases at once from patient’s saliva sample. A patient can easily order this screening service through 3billion’s website (https://3billiion.io) and receive t...

Da An Gene Co Ltd 002030 Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryDa An Gene Co Ltd Daan Gene is a medical device company that offers molecular diagnostic techniques. The company develops and produces invitro diagnostic products. It offers products such as molecular diagnostic products, repiratory infection, realtime PCR instrument, smart and easy solution for PCR, reverse dot blot product, fish product, nucleic acid extraction instrument, reference mater...

#news #biotech Gene editing can complement traditional food-animal improvements

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gene editing can complement traditional food-animal improvements .Gene editing—one of the newest and most promising tools of biotechnology—enables animal breeders to make beneficial genetic changes, without bringing along … Continue reading → Cet article #news ...

Natural resistance to Meningococcal Disease related to CFH loci: Meta-analysis of genome-wide association studies

Global Epigenetics Drugs Market Analysis: Drug Type, Mechanism of Action, Growth Trends and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.

Maryland Heights, MO, February 18, 2017 --(PR.com)-- The global epigenetics drugs market is estimated to reach USD 5.8 Billion in 2020, declining at a CAGR of 18.3% from 2016 to 2020, due to increasing demand for cancer, heart diseases, diabetes, and mental illnesses treatment worldwide. The global epigenetics drugs market growth mainly is driven by factors such as rising incidence of cancer, adv...

Caprion Biosciences to Lead Short Course and Present Poster at Molecular Medicine Tri-Conference in San Francisco

Short Course to Highlight Intracellular Cytokine Detection Assay in Adoptive Cell Therapy Trials and Poster to Highlight Metaproteomic Analysis of Gut Microbiome in Enfants MONTREAL, Feb. 17, 2017 /PRNewswire/ - Caprion Biosciences Inc. announced today that Dr. Yoav Peretz, Scientific Director of ImmuneCarta will lead a short course on novel techniques in development of Intracellular cytokine ...

Value of vigilant teeth brushing may be muted by genetic factors

Why do some thorough tooth-brushers develop tooth decay while other people who take a more relaxed attitude to dental hygiene don’t have any holes? Researchers from the University of Zurich have for the first time pinpointed a

Parents worried about passing on genetic disorders to their children have hope: Gene editing

20 percent of cancer patients resistant to chemotherapy — tweaking gene expression could help

Approximately 20 percent of all cancers have a mutation that makes them incredibly resistant to chemotherapy – a gene called KRAS. KRAS-mutant cancers also have very low survival rates because they are much harder to treat. Given this, researchers have focused their efforts on ways to inhibit KRAS activity. But scientists…have taken a unique approach that may prove to […] The p...

Selecta hires Lonza to make synthetic vector delivered gene therapy

Selecta Biosciences Inc. has hired Swiss contractor Lonza to make a gene therapy candidate for the metabolic disease, Methylmalonic Acidemia (MMA).

Genomic Decipher Score Predicts Prostate Cancer Metastasis, Mortality

The Decipher prostate cancer gene-expression classifier can predict patients’ risk of metastasis and prostate cancer-specific mortality using biopsy specimens prior to radical prostatectomy or radiotherapy plus androgen deprivation.

Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials

Arthrogen will start a Phase Ib trial for a gene therapy aiming to treat rheumatoid arthritis with a single injection and reduce costs for patients. Arthrogen, based in Amsterdam, is developing local gene therapies for inflammatory diseases. The biotech company has ... This awesome article Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials appeared first on Labiotech.eu....

Gene editing patent ruling sways fortune of biotech hopefuls

In a highly anticipated decision that could sway the fortunes of a handful of biotechnology companies, the federal patent office has turned back a challenge to patents covering a widely used method for editing genes. The office's board of appeals ruled Wednesday that the Broad Institute of MIT and Harvard can keep patents it had been awarded for a technique called CRISPR that lets scientists a...

Duke University Medical Center Release: Discovery Of A Gene Function Sheds Light On New Treatment Strategies For Amyotrophic Lateral Sclerosis (ALS)

  Life Sciences Jobs   ...

Duke University Medical Center Release: Discovery Of A Gene Function Shed Light On New Treatment Strategies For Amyotrophic Lateral Sclerosis (ALS)

  Life Sciences Jobs   ...

Exclusive CRISPR licenses slow development of therapies, legal experts argue

Exclusive licenses granted to three for-profit companies on CRISPR genome-editing technology threaten to slow therapies, patent experts say.

CRISPR Patent Battle Determined on 2/15/2017 – USPTO issues a verdict in legal tussle over rights to genome-editing technology

CRISPR Patent Battle Determined on 2/15/2017 – USPTO issues a verdict in legal tussle over rights to genome-editing technology Curator: Aviva Lev-Ari, PhD, RN Broad Institute prevails in heated dispute over CRISPR patents Sharon Begley sharon.begley@statnews.com @sxbegle In a one-sentence judgment by the Patent Trial and Appeal Board, the three judges decided that there is “no […]

MGIS Announces Sequence Health Partnership To Further Enhance Bariatric Malpractice Risk Protection

SALT LAKE CITY, Feb. 16, 2017 /PRNewswire/ -- MGIS Underwriting Managers, Inc. (MGIS), a leading provider of insurance products and services designed specifically for physicians, today announced a new partnership with Sequence Health to strengthen delivery and tracking of risk management measures designed to reduce the frequency, risk and cost of malpractice actions against bariatric surgeons...

Quick Search
Advertisement
 

review and buy Bioinformatics market research data and corporate reports here